Document |
Document Title |
WO/2019/190823A1 |
The application relates to pharmaceutically acceptable salts of [3-(4- {2-butyl-l-[4-(4-chloro-phenoxy)-phenyl]-lH-imidazol-4-yl}-p
henoxy) -propyl]-diethylamine (Azeliragon) useful in the treatment of RAGE mediated diseases such as Alzh...
|
WO/2019/187445A1 |
Provided are: an active-ray-sensitive or radiation-sensitive resin composition which can be prevented from the change in line width of a pattern due to post-exposure delay; a resist film using the active-ray-sensitive or radiation-sensit...
|
WO/2019/182463A1 |
Acid addition salt of pyrimethamine (5-4-chlorophenyl)-6-ethyl-2,4- pyrimidinediamine) and methane sulfonic acid, process for its preparation and pharmaceutical compositions comprising the acid addition salt are disclosed.
|
WO/2019/176425A1 |
The purpose of the present invention is to provide a method by which a sulfonic-acid-group-containing monomer can be produced in good yield, the monomer being usable as a raw material for fluoropolymer electrolytes such as fuel-cell diap...
|
WO/2019/178344A1 |
Novel photoacid generator compounds are provided. Compositions that include the novel photoacid generator compounds are also provided. The present disclosure further provides methods of making and using the photoacid generator compounds ...
|
WO/2019/161896A1 |
Process P1 for the manufacture of a secondary fatty alcohol, said process P1 comprising synthesizing an internal ketone K1 by a process P0 comprising the decarboxylative ketonization reaction of a fatty acid or the like in a liquid phase...
|
WO/2019/158577A1 |
The present invention relates to novel uses of stable inorganic peroxoacids as catalysts in the preparation of alkanesulfonic acids from alkanes and sulfur tri- oxide, methods for the production of alkanesulfonic acids employing said cat...
|
WO/2019/158892A1 |
The present invention relates to an industrial process for continuously preparing alkane-sulphonic acid from the corresponding alkane and sulphur trioxide, the process being carried out in a solvent, which is the alkane-sulphonic acid.
|
WO/2019/158615A1 |
The present invention relates to novel lignin-derived compounds and compositions comprising the same and their use as redox flow battery electrolytes. The invention further provides a method for preparing said compounds and compositions ...
|
WO/2019/160940A1 |
Provided herein are solid state forms of compounds, including enantiomerically pure forms thereof, and pharmaceutically acceptable salts or co-crystals and prodrugs thereof which have glucagon receptor antagonist or inverse agonist activ...
|
WO/2019/158576A1 |
The present invention relates to a process for the direct synthesis of alkanesulfonic acids, particularly methanesulfonic acid, from sulfur trioxide and alkanes employing heterogeneous catalysts, particularly transition metals such as rh...
|
WO/2019/146506A1 |
Provided is a compound and the like having excellent light resistance and storage stability. A compound characterized by having a structure represented by formula (1) or (2). [In formulas (1) and (2), R1 and R2 each independently represe...
|
WO/2019/141740A1 |
The present invention related to compounds of Formula (I): or an agronomically acceptable salt thereof, wherein Q, X, Z, R2 and R3 are as described herein. The inventions further relates to compositions comprising said compounds, to meth...
|
WO/2019/140038A1 |
The invention provides branched hydrophobes for the production of surfactants with improved properties over linear hydrophobes. The invention also provides branched C10-12 enals and aldehydes that are oxidized to branched fatty acids or ...
|
WO/2019/130866A1 |
Provided is an active ray- or radiation-sensitive resin composition which has excellent storage stability and can enable a pattern with excellent LWR performance to be obtained. Also provided are a resist film, a pattern forming method, ...
|
WO/2019/132739A1 |
The present invention relates to the field of organic chemistry and pharmacology and describes novel asymmetric derivatives of polyphenols of the dinaphthalene series of general Formula (I) or general Formula (II), a process of preparing...
|
WO/2019/124412A1 |
Provided is a sulfonic acid ester compound which is represented by formula (1). (In the formula, each of R1s-R5s independently represents a hydrogen atom, a nitro group, a cyano group, a halogen atom, an alkyl group, a halogenated alkyl ...
|
WO/2019/119191A1 |
Surfactants constructed from three synthetic building blocks that contain multiple hydrocarbon chains, ethyleneamine, and alkyl sulfonate salt groups, were shown to possess good thermal stability, and foamability, and high foam profiles....
|
WO/2019/110371A1 |
The application relates to a process for the synthesis of organic sulfonic acid salts of amino acid esters comprising the steps of (i) reacting at least one lactam with at least 3 carbon atoms in the lactam ring with at least one organic...
|
WO/2019/088800A9 |
The present invention relates to a polyethylene glycol derivative and a preparation method thereof. A preparation process of a polyethylene glycol derivative, according to the present invention, may provide a novel polyethylene glycol de...
|
WO/2019/106982A1 |
Provided are an internal olefin sulfonate composition which shows excellent hue stability and excellent aroma stability even when preserved for a long period of time, and a method for preserving an internal olefin sulfonate. The internal...
|
WO/2019/101132A1 |
Disclosed in the present invention are a fluorosulfonyl-containing compound, an intermediate thereof, a preparation method therefor and use thereof. The fluorosulfonyl-containing compound disclosed in the present invention comprises a ca...
|
WO/2019/095636A1 |
Disclosed is a method for synthesizing a benzenesulfonate derivative, which belongs to the technical field of compound synthesis. Formula (I) is used as a raw material and reacted with ethylene glycol or R2-OH to produce formula (II) or ...
|
WO/2019/094732A1 |
The present disclosure provides compounds of Formula (I), and pharmaceutically acceptable salts thereof. The compounds described herein are useful in treating diseases associated with the binding of CREB to CREB-binding protein (CBP) and...
|
WO/2019/086509A1 |
The present invention relates to crystalline rucaparib mesylate salt and to a process for its preparation. Furthermore, the invention relates to a pharmaceutical composition comprising the crystalline rucaparib mesylate salt and at least...
|
WO/2019/078027A1 |
Provided is a curable composition that makes it possible to obtain a cured product having excellent adhesion to substrates and excellent biocompatibility. Also provided are a film and a cured product having excellent adhesion to substrat...
|
WO/2019/076774A1 |
The invention relates to a method of producing a sulphonated anthraquinone compound by reacting an anthraquinone compound with oleum, then adding water and a bridging liquid, recovering the sulphonated anthraquinone compound in solid for...
|
WO/2019/068935A1 |
The present invention relates to dye molecules and to staining compositions comprising said dye molecules that are particularly suitable for selectively staining biological substrates, such as structures in the posterior eye segment and ...
|
WO/2019/068726A1 |
The present invention relates to a cellular transport system for bringing a sulfonic acid construct which carries a cargo into a cell and releasing the cargo in the cell's cytoplasm, the cellular transport system comprising: (i) a sulfon...
|
WO/2019/070595A1 |
Disclosed herein are aztreonam derivatives, therapeutic methods of using the aztreonam derivatives, particularly in combination with β-lactamase inhibitors, and pharmaceutical compositions thereof. The aztreonam derivatives can be admin...
|
WO/2019/068494A1 |
The invention relates to a method of enhancing conversion of alkali metal salt, preferably aqueous salt, preferably aqueous sodium salt of N-methyl taurine to alkyl taurate amides. In one aspect, the starting salt is pre-concentrated (at...
|
WO/2019/068355A1 |
The present invention relates to dye molecules and to staining compositions comprising said dye molecules that are particularly suitable for selectively staining biological substrates, such as structures in the posterior eye segment and ...
|
WO/2019/058885A1 |
Provided is a method for producing a compound, by which a sulfonate salt of a hydrazine compound is able to be safely produced with high yield. Also provided is a method for producing a compound, by which an acid hydrazide compound deriv...
|
WO/2019/054450A1 |
Provided is a novel method for producing a compound represented by formula (I). The present invention relates to a method for producing a compound represented by formula (TH-2), and a compound represented by formula (I) via formula (TH-2...
|
WO/2019/047493A1 |
The present invention relates to an ionic liquid, a cation of which contains a hexafluoroisopropylsulfonic acid group. The ionic liquid provided by the present invention introduces a hexafluoroisopropylsulfonic acid group into a cationic...
|
WO/2019/045064A1 |
Provided are: a polymer containing a fluorosulfonyl group having the unit represented by formula u1; a polymer containing a sulfonic acid group, which is the polymer containing a fluorosulfonyl group where the fluorosulfonyl group has be...
|
WO/2019/043587A2 |
The present invention relates to a process for the preparation of Treosulfan using sodium borohydride and iodine as reducing agent, which is less hazardous and convenient as compared to the reagents used in the prior art. The invention a...
|
WO/2019/045063A1 |
The present invention relates to: a fluorosulfonyl group-containing compound production method by which a compound represented by formula 5 is obtained using a compound represented by formula 1 as the starting material; and a fluorosulfo...
|
WO/2019/043339A1 |
The present invention relates to a method for preparing a sulfonic acid that is slightly corrosive, or even non-corrosive, with respect to stainless steels, said method comprising at least the steps of adding at least one nitrite to a su...
|
WO/2019/044462A1 |
The present invention relates to: a N,N'-diarylurea derivative represented by general formula (1); and a manufacturing method thereof. Also, the present invention relates to a thermosensitive recording material in which a thermosensitive...
|
WO/2019/043338A1 |
The present invention relates to a weakly corrosive and weakly coloured sulfonic acid, with APHA colour index less than 20, comprising chlorides and nitrites in a chloride/sulfonic acid molar ratio of between 1 ppm and 200 ppm, and a nit...
|
WO/2019/036698A1 |
The present disclosure, in general, relates to portable/transportable apparatuses, methods, and systems for generating and delivering sulfur trioxide on-site or near an item to be treated. The present disclosure also relates to portable/...
|
WO/2019/031454A1 |
Provided are: a high-purity arylsulfonic acid amine salt vinyl monomer which has both of excellent storage stability and amphipathicity such that the monomer is soluble in both of water and an organic solvent and which is an extremely in...
|
WO/2019/018422A1 |
The present disclosure pertains to peptide nucleic acid (PNA) monomers and oligomers, as well as methods and compositions useful for the preparation of PNA monomer precursors (e.g. PNA Monomer Esters, Backbone Esters and Backbone Ester A...
|
WO/2019/016293A1 |
The present invention relates to certain compounds of formula (I) wherein - Ar is (Ar1) or (Ar2) and to their uses as antibacterial agents. The invention further relates to methods of treatment of bacterial infection with such compounds,...
|
WO/2019/004114A1 |
Provided is a production method for efficiently synthesizing a compound (1-2) which is an important intermediate in production of edoxaban. The method comprises dripping a compound (1-1) into a solution A that is obtained by causing a re...
|
WO/2019/006025A1 |
Aspects of the present disclosure include antibacterial aromatic sulfonyl fluoride agents. The subject aromatic sulfonyl fluoride agents have a pharmacophore that can provide for potent antibacterial activity. The subject agents are comp...
|
WO/2019/004297A1 |
Provided is a novel nanoparticle, a contrast agent for magnetic resonance imaging containing the same, and a ligand compound used for the production of the nanoparticle. The present invention relates to a nanoparticle including: a metal ...
|
WO/2019/002447A1 |
The present invention relates to a process for the production of alkane sulfonic acid with a regulator as well as two specific compounds which can be used as regulator in a respective process.
|
WO/2018/228079A1 |
The present invention discloses a fluorescent probe for detecting a sulfenated protein, having the following structural general formula (I). The fluorescent probe has good stability and can be preserved for long-term use. The fluorescent...
|